Hypera SA (HYPMY)
4.35
+0.09
(+2.03%)
USD |
OTCM |
Mar 31, 16:00
Hypera EPS Diluted (Quarterly) : 0.13 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Raia Drogasil SA | 0.0323 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 83.35M |
| Revenue (Quarterly) | 414.66M |
| Total Expenses (Quarterly) | 331.09M |
| Enterprise Value | 4.185B |
| Gross Profit Margin (Quarterly) | 59.32% |
| Profit Margin (Quarterly) | 20.10% |
| Earnings Yield | 7.81% |
| Operating Earnings Yield | 11.41% |
| Normalized Earnings Yield | 7.805 |